8-KEarnings & ResultsExhibits & Filings

Elevance Health, Inc. 8-K Report, Financial Results (Apr 22, 2025)

Filed April 22, 2025For Securities:ELV

Summary

Elevance Health, Inc. (ELV) has filed an 8-K report on April 22, 2025, to announce its financial results for the first quarter ended March 31, 2025. This filing primarily serves as a notification of the press release containing these results, which is attached as Exhibit 99.1. Investors should refer to the press release for specific financial figures and performance metrics. The report also includes standard forward-looking statements, outlining potential risks and uncertainties that could impact the company's future financial performance. These include risks related to healthcare costs, regulatory changes, cybersecurity, competitive pressures, and government programs like Medicare and Medicaid.

Key Highlights

  • 1Elevance Health announced its Q1 2025 financial results via an 8-K filing on April 22, 2025.
  • 2The press release containing the detailed financial results is attached as Exhibit 99.1.
  • 3The filing is primarily informational, directing investors to the accompanying press release for performance data.
  • 4Standard forward-looking statements are included, highlighting potential risks and uncertainties.
  • 5Key risk factors mentioned include healthcare cost trends, regulatory impacts, and competitive landscape.
  • 6Risks related to government programs (Medicare/Medicaid) and cybersecurity are also noted.

Frequently Asked Questions

The detailed financial results for the quarter ended March 31, 2025, are provided in the press release furnished as Exhibit 99.1 to this 8-K filing.

The main purpose of this 8-K filing is to officially report that Elevance Health has issued a press release containing its first quarter 2025 financial results and to incorporate that press release by reference.

This 8-K filing primarily announces the company's financial results and does not appear to disclose new financial commitments or significant corporate events beyond the earnings release itself. Investors should review the attached press release for specific operational and financial details.

Elevance Health highlights a broad range of risks, including changes in healthcare costs and utilization, regulatory and legislative impacts, cybersecurity threats, competitive pressures, the performance of government programs like Medicare and Medicaid, and potential litigation or investigation costs.